About Satellite Bio
Satellite Bio is a Healthcare company based in Cambridge (United States) founded in 2019 by Arnav Chhabra and Christopher Chen. It operates as a proprietary implantable satellite organs are developed for cell therapy. Satellite Bio has raised $110 million across 2 funding rounds from investors including Lightspeed Venture Partners, aMoon and Polaris Partners. The company has 21 employees. Satellite Bio offers products and services including SAT Platform and Tissue Therapeutics. Its focus areas include Life Sciences, Regenerative Medicine, Bioartificial Organs and Diversified Medical Devices. Its legal entity is SATELLITE BIOSCIENCES INC. Its competitors include KaloCyte, CorNeat Vision, Stratatech Corp, Morphocell Technologies and Haimai Medical and 3 more; 5 of its 8 listed competitors have raised funding.
Company details
Satellite Bio was founded in 2019 in Cambridge, United States, and operates in the regenerative medicine sector. Proprietary implantable satellite organs are developed through synthetic biology and tissue engineering to support living therapeutic solutions. Hydrogel grafts are created, and in vitro assays are conducted as part of cell therapy efforts. Focus is placed on advancing treatments in this field.
- Headquarters Cambridge, United States
- Employees 21
- Founders Arnav Chhabra, Christopher Chen
- SectorsHealthcare
- Email••••••••
- Website satellite.bio
- Social LinkedIn
- Legal Name Satellite Biosciences Inc
- Total Equity Funding$110M (USD)
in 2 rounds
- Latest Funding Round$91M (USD), Series A
Feb 2022
- InvestorsLightspeed Venture Partners
& 5 more
- Employee Count21
Products & Services of Satellite Bio
Satellite Bio offers a comprehensive portfolio of products and services, including SAT Platform and Tissue Therapeutics.
Enables expansion and delivery of solid organ cells for regenerative therapies.
Delivers living cells to repair or replace organ functions like the liver.
Funding Insights of Satellite Bio
Satellite Bio has successfully raised a total of $110M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $91 million completed in February 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $110M
- Total Rounds 2
- Last Round Series A — $91M
- First Round $19M
(Nov 2020)
- Investors Count 6
All 2 funding rounds of Satellite Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2022 | $91M | Series A | – | aMoon | |
| Nov 2020 | $19M | Seed | – | Lightspeed Venture Partners, aMoon | – |
6 investors in total: 6 institutional.
Investors in Satellite Bio
Satellite Bio has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Lightspeed Venture Partners, aMoon and Polaris Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investing in innovative companies across global sectors is undertaken by Lightspeed Venture Partners. | 1997 | lsvp.com | Menlo Park, United States | |
Venture capital investments in healthcare are focused on by aMoon. | – | amoon.fund | - | |
US focused venture capital firm | – | polarispartners.com | Boston, United States | |
Venture capital is provided to biomedical technology startups. | – | cataliocapital.com | New York, United States | |
Waterman Ventures is focused on supporting innovative growing businesses. | – | watermanventures.nl | Utrecht, Netherlands | |
Tech startups are funded by S32, a venture capital entity. | – | s32.com | Sunnyvale, United States |
Investor details for Satellite Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Satellite Bio
29 people are tracked at Satellite Bio (8 in leadership, 14 in board & advisors, 7 in team); the tracked headcount is 21.
| Name | Role | Group |
|---|---|---|
Arnav Chhabra | Co-Founder | Leadership |
Christopher Chen | Co-Founder | Leadership |
Thomas Lowery | CTO | Leadership |
Marcus Lehmann | Associate Director, Drug Product Process Development | Leadership |
Sophie Cazanave | Senior Director | Leadership |
Diane Marcou | Consulting CFO | Leadership |
Sunil Mallanna | Senior Director & Head Of Regenerative Biology | Leadership |
Julie Morse | Vice President, Technical Operations | Leadership |
Scott Friedman | Advisor | Board & advisors |
Terrance McGuire | Advisor | Board & advisors |
Sangeeta N. Bhatia | Co-Founder | Board & advisors |
Ellie McGuire | Director | Board & advisors |
Yair Schindel | Director | Board & advisors |
Robert Langer | Advisor | Board & advisors |
Steve Kafka | Director | Board & advisors |
William Young | Director | Board & advisors |
Mani Subramanian | Advisor | Board & advisors |
Gyongyi Szabo | Advisor | Board & advisors |
Marcela Maus | Advisor | Board & advisors |
Seth Karp | Advisor | Board & advisors |
9 more people are available in the full profile.
Complete people profiles for Satellite Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Satellite Bio
3 dated milestones of Satellite Bio across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Satellite Bio is founded.
- Funding First funding round of $19.0M.
- Funding Latest funding round, Series A, of $91.0M.
Competitors of Satellite Bio
Satellite Bio has 8 listed competitors in our database, 5 of them funded. They include KaloCyte, CorNeat Vision, Stratatech Corp, Morphocell Technologies and Haimai Medical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kalocyte.com | 2016 | St. Louis, United States | $1.1M | – | Nanotechnology-based red blood cell substitutes are developed. | |
| corneat.com | 2015 | – | $4M | – | Nanotechnology-based artificial corneal implants are developed for ophthalmic use. | |
| stratatechcorp.com | 2000 | United States | $3.68M | 47 | Cell-based skin substitutes are developed for therapeutic and research uses. | |
| morphocell.com | 2018 | Montreal, Canada | – | – | Engineered liver tissues are developed for liver disease treatments. | |
| humatrix-medical.com | 2021 | Suzhou, China | – | – | Tissue engineering technologies for cardiovascular regenerative surgeries are developed. | |
| videregen.com | 2012 | Liverpool, United Kingdom | $2.59M | 8 | Tissue repair is advanced through thymus stem cell science by Videregen. | |
| golivertx.com | 2017 | Nantes, France | – | – | Develops stem cell-based therapies to repair liver without transplantation. | |
| juntenbio.co.jp | 2018 | Chiyoda, Japan | $1.85M | – | Regenerative medicine products are developed for immune tolerance induction. |
Detailed competitors of Satellite Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Diversified Medical Devices
10 companies that operate in the same segment as Satellite Bio (Diversified Medical Devices), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medical equipment for treating over 30 chronic diseases is developed. | 1949 | Minneapolis, Minnesota, United States | – | USD 36.36 B | 95,000 | |
Wide range of medical devices | 1979 | Marlborough, Massachusetts, United States | – | USD 20.07 B | 53,000 | |
Healthcare solutions are provided by Johnson & Johnson globally. | 1886 | New Brunswick, New Jersey, United States | – | USD 94.18 B | 139,800 | |
Diagnostic and surgical products for women's healthcare are provided. | 1985 | Marlborough, Massachusetts, United States | – | USD 4.1 B | 7,060 | |
Developer of drug candidates for the treatment of rare CNS disorders | 1971 | Boston, Massachusetts, United States | USD 105.8 M | – | 487 | |
Surgical instruments are manufactured for multiple therapeutic areas. | 1987 | Utica, New York, United States | – | USD 1.37 B | 3,900 | |
A wide range of medical devices is developed by HOYA. | 1941 | Tokyo, Tokyo, Japan | – | USD 5.94 B | 37,910 | |
Medical devices for cardiac and neuromodulation therapies are manufactured globally. | 1976 | Saint Paul, Minnesota, United States | – | – | – | |
Complex healthcare challenges are addressed through technology solutions by Commure. | 2016 | San Francisco, California, United States | USD 823.3 M | – | 316 | |
Provider of medical devices for emergency medicine and various health conditions | 1943 | Wayne, United States | – | USD 1.99 B | 14,100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Satellite Bio
Satellite Bio was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Satellite Bio is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Satellite Bio is a funded company, having raised a total of $110M across 2 funding rounds to date. The company's 1st funding round was a Seed of $19M, raised on Nov 2020.
Satellite Bio has 21 employees.
Satellite Bio was founded in 2019 in Cambridge, United States, and operates in the regenerative medicine sector. Proprietary implantable satellite organs are developed through synthetic biology and tissue engineering to support living therapeutic solutions. Hydrogel grafts are created, and in vitro assays are conducted as part of cell therapy efforts. Focus is placed on advancing treatments in this field.
Satellite Bio's top competitors include KaloCyte, Stratatech Corp and Morphocell Technologies.
Satellite Bio offers SAT Platform and Tissue Therapeutics.
Satellite Bio has 6 investors. Key investors include Lightspeed Venture Partners, aMoon, Polaris Partners, Catalio Capital Management, and Waterman Ventures.
Satellite Bio operates through Satellite Biosciences Inc.